Hasle-Rüegsau, Switzerland

Patrick Hostettler

This inventor holds 34 USPTO granted patents and 22 published patent applications and 28 EPO patents, primarily in Drug Delivery Devices. Top assignees: Tecpharma Licensing Ag, Ypsomed Ag, Tecmed Ag. Active years: 2010-2025.

USPTO Granted Patents = 34 

% Patents Active = 91.2

 

Average Co-Inventor Count = 4.2

ph-index = 10

Forward Citations = 849(Granted Patents)


Location History:

  • Hasle-Rüegsau, CH (2013 - 2016)
  • Hasle-Ruegsau, CH (2010 - 2022)
  • Hasle, CH (2018 - 2024)

Company Filing History:


Years Active: 2010-2025

Loading Chart...
Loading Chart...
Areas of Expertise:
Dosing System
Injection Device
Wearable Drug Delivery
Cannula Insertion
Modular Administration
Patch Pump
Blood Lancing
Dual-Function Spring
Drive Unit
Segmented Piston Rod
Coupling Mechanism
Time-Constant Delivery
34 patents (USPTO):Explore Patents

Title: The Inventor Patrick Hostettler: Revolutionizing Technology in Hasle-Ruegsau

Introduction: Patrick Hostettler, a brilliant inventor hailing from Hasle-Ruegsau, Switzerland, is known for his groundbreaking contributions to the field of technology.

Latest Patents: Patrick Hostettler's latest patents include innovative solutions in renewable energy, artificial intelligence, and sustainable transportation.

Career Highlights: With a career spanning over two decades, Hostettler has worked with top research institutions and leading tech companies to bring his ideas to life. His dedication to pushing the boundaries of innovation has led to numerous successful inventions.

Collaborations: Throughout his career, Patrick Hostettler has collaborated with renowned scientists, engineers, and designers to create cutting-edge technologies that have had a significant impact on various industries.

Conclusion: In conclusion, Patrick Hostettler's passion for innovation and his relentless pursuit of excellence have solidified his reputation as a visionary inventor in Hasle-Ruegsau and beyond.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…